Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ruben Raychaudhuri & Chaitra Ujjani. (2022) Targeted Therapy for Relapsed/Refractory Follicular Lymphoma: Focus on Clinical Utility of Tazemetostat. OncoTargets and Therapy 15, pages 193-199.
Read now
Read now
Manel Esteller. (2017) Epigenetic drugs: More than meets the eye. Epigenetics 12:5, pages 307-307.
Read now
Read now
Articles from other publishers (27)
Vanesa‐Sindi Ivanova, John Davies, Thomas Menter, Damian Wild, Anne Müller, Fatime Krasniqi, Frank Stenner, Alexandros Papachristofilou, Stefan Dirnhofer & Alexandar Tzankov. (2023) Primary bone diffuse large B‐cell lymphoma (PB‐DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB‐like mutational profile and good prognosis. Histopathology.
Crossref
Crossref
Ákos Nagy, Bence Bátai, Laura Kiss, Stefánia Gróf, Péter Attila Király, Ádám Jóna, Judit Demeter, Hermina Sánta, Árpád Bátai, Piroska Pettendi, Tamás Szendrei, Márk Plander, Gábor Körösmezey, Hussain Alizadeh, Béla Kajtár, Gábor Méhes, László Krenács, Botond Timár, Judit Csomor, Erika Tóth, Tamás Schneider, Gábor Mikala, András Matolcsy, Donát Alpár, András Masszi & Csaba Bödör. (2023)
Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of
EZH2
mutations in follicular lymphoma
. Journal of Internal Medicine 294:3, pages 295-313.
Crossref
Crossref
Cristina López, Pablo Mozas, Armando López-Guillermo & Sílvia Beà. (2022) Molecular Pathogenesis of Follicular Lymphoma: From Genetics to Clinical Practice. Hemato 3:4, pages 595-614.
Crossref
Crossref
Rada Amin & Mounia S. Braza. (2022) The follicular lymphoma epigenome regulates its microenvironment. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Mengya Zhong, Jinshui Tan, Guangchao Pan, Yuelong Jiang, Hui Zhou, Qian Lai, Qinwei Chen, Liyuan Fan, Manman Deng, Bing Xu & Jie Zha. (2021) Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma. Frontiers in Oncology 11.
Crossref
Crossref
Fei Cheng, Fang Yu, Xiaoxi Wang, Ke Huang, Hongsheng Lu & Zhaoming Wang. (2021) A Pedigree Analysis and Clonal Correlations of the Coexistence of B-Cell Lymphoma and Histiocytic/Dendritic Cell Tumor. International Journal of Surgical Pathology 29:8, pages 906-914.
Crossref
Crossref
Mariana Bastos-Oreiro, Julia Suárez-González, Cristina Andrés-Zayas, Natalia Carolina Carrión, Solsiré Moreno, Diego Carbonell, María Chicano, Paula Muñiz, Laura Sanz, Francisco Javier Diaz-Crespo, Javier Menarguez, José Luis Diez-Martín, Ismael Buño & Carolina Martínez-Laperche. (2021) Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin’s lymphoma. Scientific Reports 11:1.
Crossref
Crossref
Yuichiro Hamamoto, Yoji Kukita, Masanori Kitamura, Masako Kurashige, Hiroaki Masaie, Shigeo Fuji, Jun Ishikawa, Keiichiro Honma, Tomoko Wakasa, Hitoshi Hanamoto, Mitsuyoshi Hirokawa, Ayana Suzuki, Eiichi Morii & Shin‐ichi Nakatsuka. (2021)
Bcl‐2‐negative
IGH‐BCL2
translocation‐negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl‐2‐positive
IGH‐BCL2
translocation‐positive follicular lymphoma
. Histopathology 79:4, pages 521-532.
Crossref
Crossref
Beatriz Valle-Argos, Giorgia Chiodin, Dean J. Bryant, Joe Taylor, Elizabeth Lemm, Patrick J. Duriez, Philip J. Rock, Jonathan C. Strefford, Francesco Forconi, Richard W. Burack, Graham Packham & Freda K. Stevenson. (2021) DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity. Scientific Reports 11:1.
Crossref
Crossref
Edith Julia & Gilles Salles. (2021) EZH2 inhibition by tazemetostat: mechanisms of action, safety and efficacy in relapsed/refractory follicular lymphoma. Future Oncology 17:17, pages 2127-2140.
Crossref
Crossref
Leandro VenturuttiAri M. Melnick. (2021) The Role of Epigenetic Mechanisms in B Cell Lymphoma Pathogenesis. Annual Review of Cancer Biology 5:1, pages 311-330.
Crossref
Crossref
Cèlia Dobaño-López, Ferran Araujo-Ayala, Neus Serrat, Juan G. Valero & Patricia Pérez-Galán. (2021) Follicular Lymphoma Microenvironment: An Intricate Network Ready for Therapeutic Intervention. Cancers 13:4, pages 641.
Crossref
Crossref
Rosario Munguía-Fuentes, Raúl Antonio Maqueda-Alfaro, Rommel Chacón-Salinas, Leopoldo Flores-Romo & Juan Carlos Yam-Puc. (2021) Germinal Center Cells Turning to the Dark Side: Neoplasms of B Cells, Follicular Helper T Cells, and Follicular Dendritic Cells. Frontiers in Oncology 10.
Crossref
Crossref
María García-Álvarez, Sara Alonso-Álvarez, Isabel Prieto-Conde, Cristina Jiménez, M. Eugenia Sarasquete, M. Carmen Chillón, Alejandro Medina, Ana Balanzategui, Rebeca Maldonado, Alicia Antón, Marta Rodríguez, Oscar Blanco, Luis G. Díaz, Pilar Tamayo, Pedro Blanco, Carmen Esteban, Verónica González-Calle, Noemí Puig, Norma Gutiérrez, Alejandro Martín, Ramón García-Sanz, Marcos González, M. Dolores Caballero & Miguel Alcoceba. (2021) Genetic complexity impacts the clinical outcome of follicular lymphoma patients. Blood Cancer Journal 11:1.
Crossref
Crossref
Stephen Booth & Graham Collins. (2020) Epigenetic targeting in lymphoma. British Journal of Haematology 192:1, pages 50-61.
Crossref
Crossref
Leandro Venturutti & Ari M. Melnick. (2020) The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs. Blood 136:20, pages 2263-2274.
Crossref
Crossref
Judith A. Ferry. (2020) Scientific Advances and the Evolution of Diagnosis, Subclassification and Treatment of Lymphoma. Archives of Medical Research 51:8, pages 749-764.
Crossref
Crossref
Min Chen, Guoxiong Jiang, Yichen Liu, Dongya Li, Tiantian Li, Jie Peng, Qian Jiang, Haiyan You, Rong Ba, Jinlan Pan, Mei Li, Weiguo Long, Jinsong Yan, Yan Zhu, Yun Wang, Xiaodong Xi, Jianhua Mao & Xiaofeng Shi. (2020) Establishment and characterization of a novel ‘double‐hit’ follicular lymphoma cell line, FL‐SJC. Journal of Cellular and Molecular Medicine 24:14, pages 7928-7938.
Crossref
Crossref
Jonathan P. Belman, Wenzhao Meng, Hong Yi Wang, Jie Li, Honore T. Strauser, Aaron M. Rosenfeld, Qian Zhang, Eline T. Luning Prak & Mariusz Wasik. (2020)
Dramatic increase in gene mutational burden after transformation of follicular lymphoma into TdT
+
B-lymphoblastic leukemia/lymphoma
. Molecular Case Studies 6:1, pages a004614.
Crossref
Crossref
Eric Y. Loo. 2020. Follicular Lymphoma and Mantle Cell Lymphoma. Follicular Lymphoma and Mantle Cell Lymphoma
115
148
.
Evgeniya V. Kharchenko & John W. Sweetenham. (2019) Advances in relapsed/refractory follicular lymphoma therapeutics. ADVANCES IN CELL AND GENE THERAPY 3:1.
Crossref
Crossref
Reyad Dada. (2019) Diagnosis and management of follicular lymphoma: A comprehensive review. European Journal of Haematology 103:3, pages 152-163.
Crossref
Crossref
Grerk Sutamtewagul & Brian K. Link. (2019) Novel treatment approaches and future perspectives in follicular lymphoma. Therapeutic Advances in Hematology 10, pages 204062071882051.
Crossref
Crossref
Sarah M. Choi, Aleodor A. Andea, Min Wang, Amir Behdad, Lina Shao, Yanming Zhang, Xinyan Lu, David Dittmann, Juan Castro, Yi-Hua Chen & Juehua Gao. (2018) KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma. Diagnostic Pathology 13:1.
Crossref
Crossref
James A. Heward, Emil A. Kumar, Koorosh Korfi, Jessica Okosun & Jude Fitzgibbon. (2018) Precision medicine and lymphoma. Current Opinion in Hematology 25:4, pages 329-334.
Crossref
Crossref
Melody R. Becnel & Loretta J. Nastoupil. (2018) Follicular Lymphoma: Past, Present, and Future. Current Treatment Options in Oncology 19:7.
Crossref
Crossref
Sarah Huet, Pierre Sujobert & Gilles Salles. (2018) From genetics to the clinic: a translational perspective on follicular lymphoma. Nature Reviews Cancer 18:4, pages 224-239.
Crossref
Crossref